Review Article

Cardiac Implications of COVID-19 in Deceased and Recovered Patients: A Systematic Review

Table 4

Laboratory parameters of the included patients among the studies.

CPK MB (in ng/ml)CK (in U/L)Procalcitonin (in ng/ml)Troponin I (ng/ml)D-dimer (µg/L)Hs-CRP (mg/L)Pro-BNP (pg/ml)Creatinine (mg/dl)

AuthorTotalTotalTotalTotalTotalTotalTotalTotal
SurvivorSurvivorSurvivorSurvivorSurvivorSurvivorSurvivorSurvivor
NonsurvivorNonsurvivorNonsurvivorNonsurvivorNonsurvivorNonsurvivorNonsurvivorNonsurvivor
value value value value value value value value

Wang et al. [12]14 (10–18)90 (54–138)NA6 (5.6)203 (121–358)NANA71 (60–86)
13 (9–16)86 (53–121)1 (1.1)191 (108–327)68 (58–83)
18 (13–44)142 (87–325)5 (26.3)439 (202–1991)87 (71–130)
0.0080.0220.0010.003<0.001

Yang et al. [13]NANANANANANANANA
76.3 (27·4)
80.7 (32·3)
NA

Zhou et al. [14]NA21.5 (13·0–72·4)0.1 (0·1–0·1)4.1 (2·0–14·1)0.8 (0·4–3·2)NANANA
18.0 (12·5–52·1)0.1 (0·1–0·1)3.0 (1·1–5·5)0.6 (0·3–1·0)
39.0 (19·5–151·0)0.1 (0·1–0·5)22.2 (5·6–83·1)5.2 (1·5–21·1)
0.001<0.0001<0.0001<0.0001

Si et al. [15]NANANANANANANANA
48.5 (30.8, 128.1)
393.8 (139.9, 1700)
< 0.001

Shi et al. [16]0.96 (0.63–1.82)NA0.06 (0.04–0.13)0.006 (0.006–0.016)NA41 (12–81)189 (67–494)58 (48–70)
0.8 (0.6–1.2)0.05 (0.03–0.09)0.006 (0.006–0.011)30 (8–59)132 (58–237)55 (48–63)
3.6 (2.4–6.9)0.46 (0.14–1.58)0.235 (0.042–1.996)111 (64–191)1819 (759–5164)87 (59–160)
<0.001<0.001<0.001<0.001<0.001<0.001

Fang-fang Chen et al. [17]1.09 (0.70–2.00)NANA0.00 (0.00–0.03)NA40.1 (7.4–82.3)NA61.0 (50.0–74.5)
0.99 (0.66–1.51)0.00 (0.00–0.01)29.4 (5.0–68.6)60.0 (50.0–72.0)
3.27 (1.72–5.95)0.15 (0.03–0.78)101.0 (59.1–180.7)73.0 (54.0–112.0)
0000

Xie et al. [18]NANANANANANANANA

Chen et al. [19]NA109.0 (53.5–188.0)0.09 (0.04–0.23)8.7 (2.9–33.6)1.1 (0.5–3.2)53.4 (18.6–113.0)267.0 (48.0–821.0)76.0 (58.0–94.0)
84.0 (50.8–140.3)0.05 (0.03–0.08)3.3 (1.9–7.0)0.6 (0.3–1.3)26.2 (8.7–55.8)72.0 (20.0–185.0)66.0 (54.0–84.0)
189.0 (94.5–374.5)0.33 (0.14–0.65)40.8 (14.7–157.8)4.6 (1.3–21.0)113.0 (69.1–168.4)800.0 (389.8–1817.5)88.0 (66.0–114.0)
NANANANANANANA
Deng et al. [20]NANANANANANANANA
3.22 (1.04–21.80)65.00 (54.60, 78.75)
109.25 (35.00–170.28)89.00 (72.00, 133.50)
NANA

Wang et al. [21]1.19 (0.64, 2.56)68 (43, 112)0.07 (0.04, 0.18)0.007 (0.006, 0.046)1.02 (0.48, 3.69)5 (5, 5)NANA
0.86 (0.57, 1.21)57 (39, 88.5)0.04 (0.03, 0.07)0.044 (0.015, 0.131)0.66 (0.31, 1.36)5 (1.78, 5)
0.82 (0.56, 1.22)97.5 (57.8, 236)0.18 (0.1, 0.55)0.044 (0.015, 0.131)2.82 (0.91, 12.9)5 (5, 5)
<0.001<0.001<0.001<0.001<0.001<0.001

Amit et al. [9]NANANANANANANANA
NA
NA

Alamdari et al. [10]NANANANANANANANA
1.78  ± 2.141.68  ± 0.62
3.39  ± 2.942.13 ± 0.75
<0.0001<0.0001

Stefano Ghio et al. [11]NANANANANANANANA
11 (5-25)0.88 (0.72-1.1)
31 (15-80)1.09(0.88-1.61)
<0.001<0.001

Yukun et al. [22]NANANA15.3 (3.4, 37.7)3.09(0.8,7.1)NANA80.0 (66.5, 99.8)
3.6 (0.3,18.9)1.5(0.6, 3.1)75(65.2, 83.6)
31.4(11.0,84.2)7.0(3.3,28.0)93(74.2,125.3)
<0.001<0.0010.017

NA= not applicable. Measured in U/L, measured in pg/ml, measured in mg/L, and measured in μmol/L.